NORTEC PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID1231500536

KRS0000921945

Share capital1,121,700.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. BAŻANTÓW 4, 05-532 ŁUBNA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

NORTEC PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. BAŻANTÓW 4, 05-532 ŁUBNA

Show on map

NIP

1231500536

REGON

389970719

KRS

0000921945

Legal form

limited liability company

Register Address

UL. BAŻANTÓW 4, 05-532 ŁUBNA

Date of registration in KRS

2021-09-16

Date of commencement of economic activity

2021-09-16

Act signature

WA.XIV NS-REJ.KRS/7229/25/967

Pkd codes

28.99.Z - Manufacture of other special-purpose machinery not elsewhere classified

33.12.Z - Repair and maintenance of machinery

33.14.Z - Repair and maintenance of electrical devices

33.20.Z - Installation of industrial machinery, equipment, and devices

46.14.Z - Activity of agents involved in wholesale trade of machinery, industrial equipment, ships, and aircraft

46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods

47.12.Z - Other non-specialized retail trade

71.12.B - Engineering activities and related technical consultancy

74.14.Z - Other specialized design activities

74.99.Z - All other professional, scientific and technical activities, not elsewhere classified

Company authorities

representation authorityMANAGEMENT

representation type

SPÓŁKA JEST REPREZENTOWANA PRZEZ 2 (DWÓCH) CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE.

MANAGEMENT

Paweł Rafał Chrzanowski

Chairman Of The Board, 52 years old

Alain Pinel

Member Of The Board

Antoine Virdis

Member Of The Board

Yves Grossrieder

Member Of The Board

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2022	2023
	M PLN	M PLN	%
Assets	9,9	5,6	-43,8
Gross profit (loss)	1,5	-0	-101,8
EBITDA	1,9	0,5	-73,6
Net profit (loss)	1,2	-0,1	-105
Cash	0,1	0,4	385,9
Liabilities and provisions for liabilities	1,6	4,5	189,6
Net income from sale	6,8	6,4	-6,1
Short time liabilities	1,3	1,2	-7
Working assets	1,6	3,5	120,1
Equity capital	8,3	1,1	-87,3
Operating profit (EBIT)	1,6	0,1	-93,7
Depreciation	0,3	0,4	18,4
	%	%	p.p.
Profitability of capital	14,2	-5,6	-19,8
Equity capital to total assets	84,3	19,1	-65,2
Gross profit margin	22,4	-0,4	-22,8
EBITDA Margin	28,3	8	-20,3
	Days	Days	Days
Short term commitment turnover cycle	67	67	0